Perioperative and long-term operative outcomes after surgery for trigeminal neuralgia: microvascular decompression vs percutaneous balloon ablation

Head & Face Medicine

Table 1 Demographic Data

	BA	MVD
Age (years)	66.1 ± 1.5	55.6 ± 1.6 *
Gender (%)
Male	33(39%)	37(46%)
Female	51(61%)	43(54%)
ASA Physical Status (%)
1	8	13
2	69	67
3	20	19
4	2	1
Disease Length (Years)	7.0 ± 0.8 (0.3 – 40)	5.3 ± 0.7 (0.3 – 32)
Number of Medications **
0	7	1
1	48	43
2	36	38
3 or >	11	19
Incidence of Pre-operative Trigger Point Injections (%)	13.1	3.8 *
Incidence of prior surgery for TN (%)	26	28

* P < 0.05 compared to BA
All data reported as mean ± SEM, ** Medications use perioperatively include: Carbemazepine, Phenytoin, Baclofen, Neurontin, Depakote) used pre-operatively (%)